Limitations, agreements, and source contact

Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations · Source last updated 2026-07-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

IITDataManagement@hci.utah.edu

organization

Research Compliance Office, Huntsman Cancer Institute

phone

801-213-6215

title

IIT Data Management Team

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice